Caris Life Sciences · 2 hours ago
Molecular Science Liaison - Los Angeles, CA
Caris Life Sciences is leading a revolution in healthcare with a focus on precision medicine and cancer care. The Molecular Science Liaison is responsible for communicating the value of Caris Molecular Intelligence to physicians and other stakeholders, requiring extensive travel and engagement with the medical community.
Artificial Intelligence (AI)BiopharmaBiotechnologyHealth CareLife Science
Responsibilities
Act as a conduit of information/feedback between the medical community and Caris Life Sciences regarding current products and the needs of the medical community to enhance patient care, new research developments, clinical trial activities and therapeutic approaches
Present clinical data and educational materials to physician sites and/or conferences within an assigned region or nationally, as required by Sales and Marketing
Promote CMI to physician sites across Europe, as required by Sales and Marketing
Read and understand the scientific and technical literature in order to maintain knowledge of the therapeutic oncology field for customer engagement
Assists with other related duties and special projects as required by sales and marketing
Assist in field training contracted speakers as part of the Caris Speaker’s Bureau
Function as a field trainer of assigned region to provide an extension of our Director of Training
Regional speaking engagements (Roundtables, Grand Rounds, Tumor Boards, etc.) with physicians to broaden CMI understanding clinically
Attend select regional tradeshows, national tradeshows and participate in sales meetings to present relevant data necessary to promote CMI and educate clients in the marketplace
Commercial input/review of marketing material to reflect current molecular landscape
Qualification
Required
M.D. or Ph.D. in a biological science related to pharmacology, cancer biology, or molecular and cellular biology or equivalent training and experience required
Preferred
Prior experience in a commercial atmosphere such as Pharmaceuticals or Commercial Lab space a plus
Strong background in Molecular Oncology preferred
Company
Caris Life Sciences
Caris Life Sciences develops molecular profiling and AI-driven technologies to support precision medicine in oncology.
Funding
Current Stage
Public CompanyTotal Funding
$1.86BKey Investors
BraidwellOrbiMedSixth Street
2025-06-18IPO
2025-04-07Private Equity· $168M
2023-01-19Debt Financing· $400M
Recent News
2025-12-22
2025-12-21
2025-12-19
Company data provided by crunchbase